Skip to main content

Prolia 60mg | Prolia 60mg Injections | denosumab | Apple pharmaceuticals

Prolia 60mg | Prolia 60mg Injections | denosumab  

Apple pharmaceuticals


Prolia 60mg | Prolia 60mg Injections



Prolia 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides.

PRESCRIBED FOR
Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer.

DOSAGE

For adult :
Osteoporosis :
60mg SC (subcutaneously) once every 6 months
Injection of drug should be done in upper arm, upper thigh or abdomen
Giant Cell Tumor of bone :
120mg SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
Injection of drug should be done in upper arm, upper thigh or abdomen
Osteolytic Bone Metastases of Solid Tumors :
120mg subcutaneously every 4 weeks
Injection of drug should be done in upper arm, upper thigh or abdomen
Hypercalcemia :
Dose of 120mg Prolia tablet given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
Injection of drug should be done in upper arm, upper thigh or abdomen
Dosage and administration in pediatric :
13 years and older and 45kg or more
Giant Cell Tumor of bone:
Dose of 120mg Prolia tablet given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
OVERDOSE: 
Prolia overdose has no overdose. If occurs seek to emergency department and call poison control


MECHANISM

Denosumab linked to RANKL, a protein which is specific for the formation, function and survival of osteoclasts, the cells necessary for bone resorption. Denosumab prohibits osteoclast formation, function and survival hence, reducing bone resorption and raising bone mass and strength of the bone.


ADME

Peak plasma concentration: 6.75mcg/mL
Tmax : 10days
Without aggregation in Prolia pharmacokinetics with duration was noticed upon multiple dosing of 60 mg SC administered once every 6 months. Pharmacokinetics of Prolia will not affected by the binding antibodies formation.
Half-life is 25.4 days.


PRECAUTION

• Before to start treatment with Prolia, discuss with the doctor about any other regimens you are using (including over-the-counter drugs, vitamins, or herbal remedies). Do not take aspirin or products containing aspirin unless your doctor permits this.
Prolia injection may improve the negative effects of immuno-suppressants. Especially the risk for serious infections may be increased. Inform your doctor of any immuno-suppressive drugs you early consume.
• Not to receive any type of vaccination without your doctor's consultation while admonishing denosumab.
• Use in pregnancy only if benefit to mother outweighs risk to fetus. Consult with doctor before the treatment
• During Prolia treatment do not breastfeed your infants.


DRUG INTERACTION


No formal drug-drug interaction with denosumab during trials.
When interacting with some anticancer drug, orthopedic drugs, vaccines will lead to risk of adverse effects can be increased


CONTRAINDICATION

Prolia is contraindicated in patients having Hypocalcemia, Pregnancy, Hypersensitivity


LACTATION

Prolia 60mg is excreted into human milk is not known. Since possible for severe side effects occurs in nursing infants from Prolia 60mg injection, a decision should be considered that to discontinue nursing or discontinue the drug by giving preference of the importance of the drug to the mother.


STORAGE

Store at 2℃ to 8℃ in the original container, avoid freeze
Before to administration keep at room temperature
Prolia protect from direct light and heat.


MISSED DOSE

Take the dose immediately before next dose duration, then left off the missed dose and continue regular schedule.Avoid taking double dose at same time. Please consult the doctor for further information.


SIDE EFFECTS


Common side effects for the patient taking Prolia 60mg as follows : Fatigue, Muscle weakness, Phosphorus level reduced in blood, Nausea
Less common side effects for patients taking Prolia:
Dyspnea, Hypocalcemia, Cough, Arthralgia, Limb pain, Eczema, Headache


Contact Us


phone No      :9987711567

Email             :info@myapplepharma.com


website         

https://myapplepharma.com/prolia-60mg.php

Comments

Popular posts from this blog

Rozel 60mg injection | Rozel 60mg tablet | denosumab | Apple pharmaceuticals

Rozel 60mg injection | Rozel 60mg tablet | denosumab   Apple pharmaceuticals Rozel 60mg injection | Rozel 60mg tablet | denosumab 60mg injection | denosumab 60mg tablet  Rozel 60mg injection | Rozel 60mg tablet Rozel 60mg  belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. PRESCRIBED FOR Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture.  Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation...

Afatinib 20mg | Afatinib 20mg tablet | Xovoltib | Apple pharmaceuticals

Afatinib 20mg | Afatinib 20mg tablet   Apple pharmaceuticals Afatinib 20mg | Afatinib 20mg tablet |  Xovoltib 20mg | Xovoltib 20mg tablet Afatinib 20mg tablet Xovoltib 20mg  belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 20mg  is a prescription drugs which is used under the guidance of medical practioners. INDICATION Xovoltib 20mg  is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE Xovoltib the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of a...